Phone: 267-687-0620 Fax: 215-253-4110
LVG’s neurodegenerative disease panel tests for risk of Alzheimer’s disease, Parkinson’s disease, and dementia.
35 of the most clinically significant genes are assessed for variance in this panel.
The planning and decision-making process for treatment, psychosocial counseling, research study enrollment, and support programs for caregivers and patients is made easier with early detection of these variants. Additionally, family members of an individual with a neurodegenerative disease can assess their risk from the results of this test.